Trades on 4 secondary markets

Cellanome

Cellanome is a life-sciences technology company building multimodal single-cell analysis instrumentation. Its R3200 Platform combines live-cell imaging with single-cell transcriptomics using proprietary CellCage technology to isolate, observe, and perturb individual cells and track their dynamics ov

minimal 8.4 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Single Cell Analysis Genomics Laboratory Instruments

Cellanome is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.